EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins

Hyejin Kim, Inkyung Jung, Chan Hyeong Lee iD, Jungeun An iD, Myunggon Ko

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hyejin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Leukemia, Dioxygenases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Technology Research and Development Project, Institute for Basic Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic dysregulation, particularly alterations in DNA methylation and hydroxymethylation, plays a pivotal role in cancer initiation and progression. Ten-eleven translocation (TET) proteins catalyze the successive oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further oxidized methylcytosines in DNA, thereby serving as central modulators of DNA methylation–demethylation dynamics. TET loss of function is causally related to neoplastic transformation across various cell types while its genetic or pharmacological activation exhibits anti-cancer effects, making TET proteins promising targets for epigenetic cancer therapy. Here, we developed a robust cell-based screening system to identify novel TET activators and evaluated their potential as anti-cancer agents. Using a carefully curated library of 4533 compounds provided by the National Cancer Institute, Bethesda, MD, USA, we identified mitoxantrone as a potent TET agonist. Through rigorous validation employing various assays, including immunohistochemistry and dot blot studies, we demonstrated that mitoxantrone significantly elevated 5hmC levels. Notably, this elevation manifested only in wild-type (WT) but not TET-deficient mouse embryonic fibroblasts, primary bone marrow-derived macrophages, and leukemia cell lines. Furthermore, mitoxantrone-induced cell death in leukemia cell lines occurred in a TET-dependent manner, indicating the critical role of TET proteins in mediating its anti-cancer effects. Our findings highlight mitoxantrone’s potential to induce tumor cell death via a novel mechanism involving the restoration of TET activity, paving the way for targeted epigenetic therapies in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsLeukemiaDioxygenasesAnimalsMiceMitoxantroneDNA-Binding ProteinsFibroblastsDNA Methylation5-MethylcytosineEpigenesis, Genetic

Stichwörter der Autor:innen

DNA methylationTET proteinscancer therapycell-based screeningepigenetic dysregulationhydroxymethylationmitoxantrone

Substanzen

MitoxantroneDNA-Binding Proteins5-MethylcytosineDioxygenases

Autor:innen und Institutionen

  • Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
  • Department of Life Sciences, Jeonbuk National University, Jeonju 54896, Republic of Korea.
  • Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea.

ORCID-Profile: Chan Hyeong Lee, Jungeun An

Förderung

  • National Research Foundation of Korea
  • Korea Health Technology Research and Development Project
  • Institute for Basic Science
  • Korean government
  • Ministry of Health and Welfare
  • Center for Genomic Integrity, Institute for Basic Science

Zitieren

APA

Kim, H., Jung, I., Lee, C. H., An, J., & Ko, M. (2023). Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216375

Vancouver

Kim H, Jung I, Lee CH, An J, Ko M. Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216375

BibTeX
@article{Kim2023,
  author = {Kim, Hyejin and Jung, Inkyung and Lee, Chan Hyeong and An, Jungeun and Ko, Myunggon},
  title = {Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216375}
}
Kostenlos starten →